Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2005-04-18 | Max Link, Ph.D. has been one of our directors since 1996. Dr. Link is also a Chairman of the Audit & Finance Committee of the Board and a member of the Compensation Committee of the Board. Each director who is not our employee receives a quarterly fee of $3,000 and $1,000 per quarter per committee (aggregate for all committees) in which he/she is a member. The Chairman of each of the Audit and Finance and Compensation Committee is paid an additional $500 per quarter. |
| 2006-04-25 | Dr. Link is a member of both the Nominating and Corporate Governance Committee, and the Audit & Finance Committee of the Board. |
| Filing Date | Source Excerpt |
|---|---|
| 2009-05-11 | Max Link, Ph.D. (68), our Chairman of the Board, has been a director since 1996. ... The following table sets forth the compensation paid to our directors other than our Chief Executive Officer for 2008: ... Max Link, Ph.D. 118,000 Fees Earned or Paid in Cash, 11,225 Option Awards, 129,225 Total. |
| 2010-05-18 | Max Link, Ph.D. (69), our Chairman of the Board, has been a director since 1996. ... Director Compensation Table ... Max Link, Ph.D. 132,250 Fees Earned or Paid in Cash, 44,400 Option Awards, 176,650 Total. ... Mr. Link is Chairman of the Board. ... Mr. Link is a member of the Audit Committee, Compensation Committee, and Nomination and Governance Committee. |
| 2011-05-17 | Max Link, Ph.D. (70), our Chairman of the Board, has been a director since 1996. Director Compensation Table shows total compensation of $155,250. |
| 2012-04-02 | Max Link, Ph.D. (71), our Chairman of the Board, has been a director since 1996. ... The following table sets forth the compensation paid to our directors other than our Chief Executive Officer for 2011: Max Link, Ph.D., Chairman 102,250 Fees Earned or Paid in Cash, 26,450 Option Awards, Total 128,700. |
| 2013-05-17 | Max Link, Ph.D. (72), our Chairman of the Board, has been a director since 1996. ... The following table sets forth the compensation paid to our directors other than our Chief Executive Officer for 2012: ... Max Link, Ph.D., Chairman ... $105,250 Fees Earned or Paid in Cash ... $175,450 Option Awards ... $280,700 Total. ... Mr. Link is member of the Audit and Compensation Committees. |
| 2014-05-01 | Max Link, Ph.D. (73), our Chairman of the Board, has been a director since 1996. Dr. Link has been retired from business since 2003. From March 2002 until its acquisition by Zimmer Holdings, Dr. Link served as Chairman and CEO of Centerpulse, Ltd. From May 1993 to June 1994, Dr. Link served as the Chief Executive Officer of Corange Ltd. (the holding company for Boehringer Mannheim Therapeutics, Boehringer Mannheim Diagnostics and DePuy International). From 1992 to 1993, Dr. Link was Chairman of Sandoz Pharma, Ltd. From 1987 to 1992, Dr. Link was the Chief Executive Officer of Sandoz Pharma and a member of the Executive Board of Sandoz, Ltd., Basel. Prior to 1987, Dr. Link served in various capacities with the United States operations of Sandoz, including President and Chief Executive Officer. Dr. Link currently serves as a director of Alexion Pharmaceuticals, Inc. and Celsion Corporation, Inc., and has previously served on the Boards of Directors of Cell Therapeutics, Inc., Columbia Laboratories, Inc., Human Genome Sciences, Inc., Protein Design Laboratories and Discovery Laboratories, Inc., each a listed public company. The following table sets forth the compensation paid to our directors other than our Chief Executive Officer for 2013: Max Link, Ph.D., Chairman, Fees Earned or Paid in Cash: $104,000, Option Awards: $363,060, Total: $467,060. Dr. Link serves on the Audit Committee and Compensation Committee. |
Data sourced from SEC filings. Last updated: 2025-12-07